rs60554135
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001277115.2(DNAH11):c.9102+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,046,238 control chromosomes in the GnomAD database, including 5,609 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 475 hom., cov: 24)
Exomes 𝑓: 0.11 ( 5134 hom. )
Consequence
DNAH11
NM_001277115.2 intron
NM_001277115.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0290
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 7-21765609-G-A is Benign according to our data. Variant chr7-21765609-G-A is described in ClinVar as [Benign]. Clinvar id is 257939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-21765609-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.109 AC: 9475AN: 86780Hom.: 474 Cov.: 24 show subpopulations
GnomAD3 genomes
AF:
AC:
9475
AN:
86780
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.102 AC: 12758AN: 125624 AF XY: 0.105 show subpopulations
GnomAD2 exomes
AF:
AC:
12758
AN:
125624
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.107 AC: 102535AN: 959374Hom.: 5134 Cov.: 30 AF XY: 0.107 AC XY: 50816AN XY: 475784 show subpopulations
GnomAD4 exome
AF:
AC:
102535
AN:
959374
Hom.:
Cov.:
30
AF XY:
AC XY:
50816
AN XY:
475784
Gnomad4 AFR exome
AF:
AC:
832
AN:
26728
Gnomad4 AMR exome
AF:
AC:
1613
AN:
28366
Gnomad4 ASJ exome
AF:
AC:
1082
AN:
14920
Gnomad4 EAS exome
AF:
AC:
9587
AN:
33314
Gnomad4 SAS exome
AF:
AC:
6858
AN:
65660
Gnomad4 FIN exome
AF:
AC:
1669
AN:
28400
Gnomad4 NFE exome
AF:
AC:
75472
AN:
717822
Gnomad4 Remaining exome
AF:
AC:
4829
AN:
40902
Heterozygous variant carriers
0
3191
6382
9572
12763
15954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2976
5952
8928
11904
14880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.109 AC: 9479AN: 86864Hom.: 475 Cov.: 24 AF XY: 0.112 AC XY: 4607AN XY: 41210 show subpopulations
GnomAD4 genome
AF:
AC:
9479
AN:
86864
Hom.:
Cov.:
24
AF XY:
AC XY:
4607
AN XY:
41210
Gnomad4 AFR
AF:
AC:
0.0487976
AN:
0.0487976
Gnomad4 AMR
AF:
AC:
0.115034
AN:
0.115034
Gnomad4 ASJ
AF:
AC:
0.0778816
AN:
0.0778816
Gnomad4 EAS
AF:
AC:
0.293226
AN:
0.293226
Gnomad4 SAS
AF:
AC:
0.156968
AN:
0.156968
Gnomad4 FIN
AF:
AC:
0.0888735
AN:
0.0888735
Gnomad4 NFE
AF:
AC:
0.125448
AN:
0.125448
Gnomad4 OTH
AF:
AC:
0.154321
AN:
0.154321
Heterozygous variant carriers
0
424
849
1273
1698
2122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Mar 15, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 7 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at